Berberine counteracts insulin resistance by activating two proteins, sirtuin 1 (SIRT1), an acetylase, and AMPK, as a result of activation of SIRT-1 and AMPK pathways, adiponectin concentration increases, and increasing adiponectin is associated with regulation of β oxidation and glucose metabolism (38). The gene discussed is ADIPOQ; the disease is Insulin resistance.